LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 2.24 | 21.74 | 676 | 183 | 3.6825 | 2.0547 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 2.24 | 21.74 | 673 | 183 | 3.6661 | 2.0503 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 2 | 317 | 0.0063 | -0.4602 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 798 | 317 | 2.5111 | 1.5373 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 807 | 317 | 2.5394 | 1.5446 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 762 | 317 | 2.3978 | 1.5072 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 4.24 | 21.74 | 792 | 317 | 2.4922 | 1.5323 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 9 | 392 | 0.0230 | -0.1905 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 898 | 392 | 2.2908 | 1.4395 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 963 | 392 | 2.4566 | 1.4807 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 897 | 392 | 2.2883 | 1.4389 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 2 | 392 | 0.0051 | -0.4355 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 6.21 | 21.74 | 892 | 392 | 2.2755 | 1.4356 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.19 | 21.74 | 21 | 439 | 0.0477 | -0.0079 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.19 | 21.74 | 995 | 439 | 2.2621 | 1.4140 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.19 | 21.74 | 1019 | 439 | 2.3167 | 1.4273 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | N10 |